SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
07-Mar-24 4:44 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 06-Mar-24 | Sale | 34,811 | $5.60 | $194,942.00 | (7%) 530.74K to 495.93K | |
22-Feb-24 4:27 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 20-Feb-24 | Grant | 196,153 | -- | -- | 59% 334.59K to 530.74K | |
06-Mar-23 4:29 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Grant | 229,421 | -- | -- | 203% 113.09K to 342.51K | |
06-Mar-23 4:29 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-23 | Sale | 11,296 | $8.94 | $100,986.00 | (3%) 342.51K to 331.21K | |
04-Mar-22 4:12 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-22 | Grant | 8,500 | -- | -- | 726% 1.17K to 9.67K | |
04-Mar-22 4:12 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 02-Mar-22 | Sale | 3,060 | $12.01 | $36,750.60 | (32%) 9.67K to 6.61K | |
11-May-21 4:53 PM View: | Aurinia Pharmaceuticals Inc. (AUPH) | 11-May-21 | Market Purchase | 1,000 | $9.74 | $9,740.00 | 100% 0 to 1.0K | 22% |
11-Jun-20 8:39 PM View: | Avalo Therapeutics, Inc. (CERC) | 08-Jun-20 | Payment of Exercise | 4,472 | $3.22 | $14,399.80 | (10%) 45.05K to 40.58K | 7% |
11-Dec-19 4:41 PM View: | Avalo Therapeutics, Inc. (CERC) | 10-Dec-19 | Private Purchase | 2,598 | $2.85 | $7,397.81 | 6% 46.18K to 48.78K | |
11-Jun-19 8:47 PM View: | Avalo Therapeutics, Inc. (CERC) | 10-Jun-19 | Private Purchase | 1,179 | $2.85 | $3,357.20 | 3% 45.0K to 46.18K | |
13-Apr-20 6:30 PM View: | Avalo Therapeutics, Inc. (CERC) | 07-Jun-19 | Payment of Exercise | 3,723 | $4.85 | $18,056.50 | (8%) 48.78K to 45.05K | 39% |
16-Jul-18 5:12 PM View: | Avalo Therapeutics, Inc. (CERC) | 12-Jul-18 | Grant | 45,000 | -- | -- | 100% 0 to 45.0K |